
GC73196
RET-IN-21
Also known as 4-[5-(pyridin-4-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]benzamide
RET-IN-21 is an inhibitor of receptor tyrosine kinase (RET), with the IC50 of 4·4 μM, that has antitumor activity
ChemicalCAS2414373-42-3MW344.37FormulaC19H16N6O
- CAS number
- 2414373-42-3
- Molecular weight
- 344.37
- Formula
- C19H16N6O
- Solubility
- DMSO : 125 mg/mL (362·98 mM; Need ultrasonic)
- InChIKey
- DICBAYNNPUCOOQ-UHFFFAOYSA-N
- Catalogue number
- GC73196
- Brand
- GLPBIO
Computed properties PubChem CID 154729143 · XLogP 1.6 · TPSA 98.2 Ų · H-bond donors 2
- XLogP
- 1.6
- TPSA
- 98.2 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Rotatable bonds
- 5
- Heavy atoms
- 26
SMILES C1=CC(=CC=C1C2=C3N=C(C=CN3N=C2)NCC4=CC=NC=C4)C(=O)N
Computed descriptors from PubChem (CID 154729143), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il